The Center for Molecular Medicine is operated by the Pruss family and run by a team of medical professionals. It is supported by the expertise of a multidisciplinary team of international experts – medical doctors, bio scientists, and pharmacists.


is the member of the Board of RCLIN Swiss SA, which operates the Center for Molecular Medicine. Dr. Pruss is the owner and Medical Director of RCLIN Group, where she is responsible for strategic management of the medical services, research and development. Dr. Pruss no longer sees patients as a practicing doctor, while her time is dedicated to developing new services and looking for the most effective treatments.

Maria Elisabeth Pruss

is the Administrative Director of the Center for Molecular Medicine. She holds a management degree from l’Ecole des Hautes Etudes Commerciales de l’Université de Lausanne and she studied Entrepreneurship at the MIT Sloan School of Business (Cambridge, USA). Her prior experience includes working for an international marketing agency and developing two start-ups.